4.7 Article

Neuroprotective effects of oxymatrine on hypoxic-ischemic brain damage in neonatal rats by activating the Wnt/β-catenin pathway

Related references

Note: Only part of the references are listed.
Article Neurosciences

Neuroprotective Effects of Purpurin Against Ischemic Damage via MAPKs, Bax, and Oxidative Stress Cascades in the Gerbil Hippocampus

Woosuk Kim et al.

Summary: Purpurin has significant therapeutic effects on oxidative stress in HT22 cells and ischemic damage in gerbil hippocampus by improving cell survival, reducing DNA fragmentation and reactive oxygen species, inhibiting apoptosis-related protein levels, and decreasing inflammatory responses.

MOLECULAR NEUROBIOLOGY (2022)

Article Multidisciplinary Sciences

Engineered Wnt ligands enable blood-brain barrier repair in neurological disorders

Maud Martin et al.

Summary: In this study, scientists successfully engineered Wnt7a ligands into BBB-specific Wnt activators using gene engineering methods. These new Gpr124/Reck-specific agonists protected BBB function and mitigated glioblastoma expansion and ischemic stroke infarction. This study reveals the adjustable signaling specificity of Wnt ligands and provides a new modality for treating CNS disorders by normalizing the BBB.

SCIENCE (2022)

Article Biochemistry & Molecular Biology

Role of Nuclear-Receptor-Related 1 in the Synergistic Neuroprotective Effect of Umbilical Cord Blood and Erythropoietin Combination Therapy in Hypoxic Ischemic Encephalopathy

Joo-Wan Choi et al.

Summary: This study analyzed the mechanisms underlying the effect of combination treatment with EPO and UCB for hypoxic-ischemic encephalopathy (HIE). The results suggested that the synergistic neuroprotective effect of UCB and EPO combination treatment is mediated through the regulation of Nurr1 via the Wnt/β-catenin pathway.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Pharmacology & Pharmacy

Physiological and pharmacological modulation of BAX

Adam Z. Spitz et al.

Summary: In this article, recent studies on the activation of BAX protein are discussed, providing structure-function insights and identifying regulatory surfaces that control BAX activation. The development of small molecule modulators is emphasized as a novel approach towards understanding and targeting BAX for therapeutic purposes.

TRENDS IN PHARMACOLOGICAL SCIENCES (2022)

Review Pharmacology & Pharmacy

Activation of Wnt/Beta-Catenin Signaling Pathway as a Promising Therapeutic Candidate for Cerebral Ischemia/Reperfusion Injury

Zhizhun Mo et al.

Summary: Stroke is a leading cause of death and survivors often suffer from severe neurological and motor deficits. The Wnt signaling pathway has been found to play a key role in the pathogenesis of stroke and reactivating this pathway can have significant therapeutic effects. A comprehensive understanding of the role of Wnt signaling in different cell types can help evaluate its potential value for stroke treatment.

FRONTIERS IN PHARMACOLOGY (2022)

Review Biochemistry & Molecular Biology

Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities

Jiaqi Liu et al.

Summary: This article provides a comprehensive review of the Wnt/β-catenin pathway, including its origin, composition, function, and clinical trials. It also discusses the challenges and opportunities for developing small-molecule compounds targeting this signaling pathway in disease treatment.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Review Clinical Neurology

Wnt/β-Catenin Signaling in Neural Stem Cell Homeostasis and Neurological Diseases

Juanmei Gao et al.

Summary: The Wnt/beta-catenin signaling pathway plays a crucial role in regulating the balance of neural stem/progenitor cells (NSCs) proliferation and differentiation, which is essential for the development and maintenance of the nervous system. Recent findings suggest that components of the Wnt/beta-catenin signaling pathway are involved in the regulation of functional brain circuits, providing potential therapeutic targets for neurological diseases.

NEUROSCIENTIST (2021)

Article Neurosciences

GSK-3β inhibitor TWS119 alleviates hypoxic-ischemic brain damage via a crosstalk with Wnt and Notch signaling pathways in neonatal rats

Limin Gao et al.

Summary: The study found that TWS119 can protect the neonatal rat brain from hypoxic-ischemic injury by activating the Wnt/beta-catenin signaling pathway and suppressing the Notch signaling pathway. TWS119 improved tissue structure, reduced cell apoptosis, and upregulated the expression of synaptic proteins in the neonatal rat brain 7 days after the injury. It also activated the Wnt/beta-catenin pathway and suppressed the Notch pathway 24 hours after the injury.

BRAIN RESEARCH (2021)

Article Clinical Neurology

Association of Increased Seizures During Rewarming With Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up A Nested Multisite Cohort Study

Lina F. Chalak et al.

Summary: The study revealed that neonates are more likely to experience electrographic seizures during rewarming after hypothermia, and these seizures are associated with an increased risk of death or disability at the 2-year follow-up.

JAMA NEUROLOGY (2021)

Review Biochemistry & Molecular Biology

Free Radicals and Neonatal Brain Injury: From Underlying Pathophysiology to Antioxidant Treatment Perspectives

Silvia Martini et al.

Summary: Free radicals play a crucial role in neonatal brain injury, with different profiles of injury identified based on the pathophysiological mechanisms and specific neonatal characteristics. While potential biomarkers for oxidative damage have been discovered, treatments such as therapeutic hypothermia and magnesium sulfate with antioxidant properties have become standard care to reduce the risk of brain injury in neonates. The implementation of currently available evidence is essential for optimizing neonatal neuroprotection and improving the neurological outcome of this population.

ANTIOXIDANTS (2021)

Article Anatomy & Morphology

Neuropeptides in the developing human hippocampus under hypoxic-ischemic conditions

Joaquin Gonzalez Fuentes et al.

Summary: The perinatal period is critical for newborn survival and human brain development, with perinatal hypoxia-ischemia being a major cause of neonatal mortality. Damage in the hippocampus due to hypoxia-ischemia is region-dependent, affecting certain vulnerable neuron populations, as shown in both animal models and adult human studies.

JOURNAL OF ANATOMY (2021)

Review Neurosciences

Hypoxic-ischemic-related cerebrovascular changes and potential therapeutic strategies in the neonatal brain

Clemence Disdier et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2020)

Review Cell Biology

Current Evidence on Cell Death in Preterm Brain Injury in Human and Preclinical Models

Anita C. Truttmann et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Hypoxic-Ischemic Encephalopathy and Mitochondrial Dysfunction: Facts, Unknowns, and Challenges

Marianela Rodriguez et al.

ANTIOXIDANTS & REDOX SIGNALING (2020)

Review Pharmacology & Pharmacy

Targeting the Wnt/β-catenin pathway in neurodegenerative diseases: recent approaches and current challenges

Annalucia Serafino et al.

EXPERT OPINION ON DRUG DISCOVERY (2020)

Review Pharmacology & Pharmacy

The role of DKK1 in Alzheimer's disease: A potential intervention point of brain damage prevention?

Chao Ren et al.

PHARMACOLOGICAL RESEARCH (2019)

Review Clinical Neurology

Therapeutic Hypothermia in Neonatal Hypoxic-Ischemic Encephalopathy

Guido Wassink et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2019)

Article Pediatrics

Plasma Biomarkers of Brain Injury in Neonatal Hypoxic-Ischemic Encephalopathy

An N. Massaro et al.

JOURNAL OF PEDIATRICS (2018)

Review Clinical Neurology

Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment

Edibe Pembegul Yildiz et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)

Review Clinical Neurology

Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment

Edibe Pembegul Yildiz et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)

Review Biochemistry & Molecular Biology

Connecting mitochondrial dynamics and life-or-death events via Bcl-2 family proteins

Abdel Aouacheria et al.

NEUROCHEMISTRY INTERNATIONAL (2017)

Article Medicine, General & Internal

Survival and Neurodevelopmental Outcomes among Periviable Infants

Noelle Younge et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Neurosciences

Mitochondrial function in hypoxic ischemic injury and influence of aging

P. Benson Ham et al.

PROGRESS IN NEUROBIOLOGY (2017)

Review Neurosciences

Cell Death in the Developing Brain after Hypoxia-Ischemia

Claire Thornton et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Early diagnosis and outcome prediction of neonatal hypoxic-ischemic encephalopathy with color Doppler ultrasound

B. Guan et al.

DIAGNOSTIC AND INTERVENTIONAL IMAGING (2017)

Review Medicine, Research & Experimental

The role of the Wnt canonical signaling in neurodegenerative diseases

Rosaliana Libro et al.

LIFE SCIENCES (2016)

Review Pediatrics

Hypoxic-Ischemic Encephalopathy A Review for the Clinician

Martha Douglas-Escobar et al.

JAMA PEDIATRICS (2015)

Article Cell Biology

Wnt Proteins

Karl Willert et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)

Article Cell Biology

TCF/LEFs and Wnt Signaling in the Nucleus

Ken M. Cadigan et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)

Review Pharmacology & Pharmacy

GSK3 beta: role in therapeutic landscape and development of modulators

S. Phukan et al.

BRITISH JOURNAL OF PHARMACOLOGY (2010)

Review Biochemistry & Molecular Biology

GSK3: a multifaceted kinase in Wnt signaling

Dianqing Wu et al.

TRENDS IN BIOCHEMICAL SCIENCES (2010)

Review Developmental Biology

Perinatal hypoxic-ischemic brain damage: Evolution of an animal model

RC Vannucci et al.

DEVELOPMENTAL NEUROSCIENCE (2005)

Article Clinical Neurology

Increased susceptibility of S100B transgenic mice to perinatal hypoxia-ischemia

MS Wainwright et al.

ANNALS OF NEUROLOGY (2004)

Article Biochemistry & Molecular Biology

DKK1, a negative regulator of Wnt signaling, is a target of the β-catenin/TCF pathway

A Niida et al.

ONCOGENE (2004)